Neurontin vs. Lamictal cd: side effect and effectiveness comparison - a phase IV clinical study
Summary:
We compare the side effects and drug effectiveness of Neurontin and Lamictal cd. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 504,640 people who take Neurontin and Lamictal cd, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
504,640 people who take Neurontin and Lamictal cd are studied.
What is Neurontin?
Neurontin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 103,948 Neurontin users for its effectiveness, alternative drugs and more.
What is Lamictal cd?
Lamictal cd has active ingredients of lamotrigine. It is often used in bipolar disorder. eHealthMe is studying from 1,228 Lamictal cd users for its effectiveness, alternative drugs and more.
Number of reports submitted per year:
Drugs being compared in this study:
- Lamictal Cd (lamotrigine)
- Neurontin (gabapentin)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Neurontin:
- not at all: 5.95 %
- somewhat: 30.38 %
- moderate: 35.48 %
- high: 20.42 %
- very high: 7.77 %
Lamictal Cd:
- not at all: 3.27 %
- somewhat: 17.36 %
- moderate: 30.69 %
- high: 32.22 %
- very high: 16.47 %
Want to compare Neurontin with Lamictal cd?
Personalize this study to your gender and age (0-99+).How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Alonso-Navarro H, Montes JM, Plaza-Nieto JF, Jiménez-Jiménez FJ, "Cataplexy Possibly Associated With Lamotrigine", Journal of clinical psychopharmacology, 2016 Aug .
- Gupta MC, Khanna J, Mathur R, Mittal N, "Lamotrigine-induced fulminant hepatic failure: an unusual presentation", IMSEAR, 2015 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Neurontin (100,524 reports)
- Lamictal cd (1,109 reports)
Common Neurontin side effects:
- Drug ineffective: 8,912 reports
- Pain: 8,900 reports
- Fatigue (feeling of tiredness): 7,503 reports
- Weakness: 6,303 reports
- Stress and anxiety: 5,947 reports
Browse all side effects of Neurontin:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Lamictal cd side effects:
- Rashes (redness): 283 reports
Browse all side effects of Lamictal cd:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on gabapentin and lamotrigine (the active ingredients of Neurontin and Lamictal cd, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Pred Forte and Cognitive Disorder - 22 seconds ago
- Eupressyl and Brain Herniation - 23 seconds ago
- Lipitor and Coagulation Time Shortened - 27 seconds ago
- Belsomra and Irritable Bowel Syndrome - 36 seconds ago
- Celestone and Dilatation Ventricular - 45 seconds ago
- Iodixanol and Pulse Absent - 50 seconds ago
- Rezulin and Taste - Impaired - a minute ago
- Sulindac and Gingival Disorder - a minute ago
- Testosterone Enanthate and Stubbornness - a minute ago
- How effective is Aspirin for Hemorrhoids? - a minute ago